Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2017 Dec 7

PMID 29211044

Citations 22

Authors

Anna A Boyko

Natalya I Troyanova

Elena I Kovalenko

Alexander M Sapozhnikov

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common age-related neurodegenerative disorders. Both diseases are characterized by chronic inflammation in the brain-neuroinflammation. The first signs of PD and AD are most often manifested in old age, in which the immune system is usually characterized by chronic inflammation, so-called "inflammaging" In recent years, there is growing evidence that pathogenesis of these diseases is connected with both regional and peripheral immune processes. Currently, the association of clinical signs of PD and AD with different characteristics of patient immune status is actively being researched. In this mini-review we compare the association of PD and AD alterations of a number of immune system parameters connected with the process of inflammation.

Citing Articles

Inflammatory Markers and Risk of Parkinson's Disease: A Population-Based Analysis.

Wang H, Li W, Lai Q, Huang Q, Ding H, Deng Z Parkinsons Dis. 2025; 2024():4192853.

PMID: 39780847 PMC: 11707066. DOI: 10.1155/padi/4192853.

Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson's disease.

Kulski J, Suzuki S, Shiina T, Pfaff A, Koks S Front Immunol. 2024; 15:1349030.

PMID: 38590523 PMC: 10999589. DOI: 10.3389/fimmu.2024.1349030.

RT-DOb, a switch gene for the gene pair {Csf1r, Milr1}, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.

Khayer N, Motamed N, Marashi S, Goshadrou F PLoS One. 2023; 18(7):e0288134.

PMID: 37410787 PMC: 10325119. DOI: 10.1371/journal.pone.0288134.

Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson's Disease.

Ravenhill S, Evans A, Crewther S Antioxidants (Basel). 2023; 12(5).

PMID: 37237983 PMC: 10215182. DOI: 10.3390/antiox12051117.

Novel patients with NHLRC2 variants expand the phenotypic spectrum of FINCA disease.

Tallgren A, Kager L, OGrady G, Tuominen H, Korkko J, Kuismin O Front Neurosci. 2023; 17:1123327.

PMID: 37179546 PMC: 10173879. DOI: 10.3389/fnins.2023.1123327.

References

Bonotis K, Krikki E, Holeva V, Aggouridaki C, Costa V, Baloyannis S . Systemic immune aberrations in Alzheimer's disease patients. J Neuroimmunol. 2007; 193(1-2):183-7. DOI: 10.1016/j.jneuroim.2007.10.020. View

Sanyal J, Bandyopadhyay S, Banerjee T, Mukherjee S, Chakraborty D, Ray B . Plasma levels of lipid peroxides in patients with Parkinson's disease. Eur Rev Med Pharmacol Sci. 2009; 13(2):129-32. View

Alvarez A, Cacabelos R, Sanpedro C, Garcia-Fantini M, Aleixandre M . Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging. 2006; 28(4):533-6. DOI: 10.1016/j.neurobiolaging.2006.02.012. View

Medana I, Gallimore A, Oxenius A, Martinic M, Wekerle H, Neumann H . MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway,. Eur J Immunol. 2001; 30(12):3623-33. DOI: 10.1002/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F. View

van Eden W, van der Zee R, Prakken B . Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol. 2005; 5(4):318-30. DOI: 10.1038/nri1593. View

Burbulla L, Song P, Mazzulli J, Zampese E, Wong Y, Jeon S . Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. Science. 2017; 357(6357):1255-1261. PMC: 6021018. DOI: 10.1126/science.aam9080. View

van Noort J . Stress proteins in CNS inflammation. J Pathol. 2007; 214(2):267-75. DOI: 10.1002/path.2273. View

Guerreiro R, Santana I, Bras J, Santiago B, Paiva A, Oliveira C . Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener Dis. 2007; 4(6):406-12. DOI: 10.1159/000107700. View

Cifuentes R, Murillo-Rojas J . Alzheimer's disease and HLA-A2: linking neurodegenerative to immune processes through an in silico approach. Biomed Res Int. 2014; 2014:791238. PMC: 4150521. DOI: 10.1155/2014/791238. View

10.

Licastro F, Pedrini S, Caputo L, Annoni G, Davis L, Ferri C . Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. J Neuroimmunol. 2000; 103(1):97-102. DOI: 10.1016/s0165-5728(99)00226-x. View

11.

Giffard R, Xu L, Zhao H, Carrico W, Ouyang Y, Qiao Y . Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J Exp Biol. 2004; 207(Pt 18):3213-20. DOI: 10.1242/jeb.01034. View

12.

Corsi M, Licastro F, Porcellini E, Dogliotti G, Galliera E, Lamont J . Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration. Biogerontology. 2011; 12(5):451-4. DOI: 10.1007/s10522-011-9335-6. View

13.

Mecocci P, Polidori M, Cherubini A, Ingegni T, Mattioli P, Catani M . Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol. 2002; 59(5):794-8. DOI: 10.1001/archneur.59.5.794. View

14.

Pockley A, Henderson B, Multhoff G . Extracellular cell stress proteins as biomarkers of human disease. Biochem Soc Trans. 2014; 42(6):1744-51. DOI: 10.1042/BST20140205. View

15.

Malik M, Parikh I, Vasquez J, Smith C, Tai L, Bu G . Genetics ignite focus on microglial inflammation in Alzheimer's disease. Mol Neurodegener. 2015; 10:52. PMC: 4595327. DOI: 10.1186/s13024-015-0048-1. View

16.

Ma S, Tang N, Tam C, Lui V, Suen E, Chiu H . Association between HLA-A alleles and Alzheimer's disease in a southern Chinese community. Dement Geriatr Cogn Disord. 2008; 26(5):391-7. DOI: 10.1159/000164275. View

17.

Bloom G . Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014; 71(4):505-8. DOI: 10.1001/jamaneurol.2013.5847. View

18.

Xilouri M, Stefanis L . Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases. Mol Cell Neurosci. 2015; 66(Pt A):29-36. DOI: 10.1016/j.mcn.2015.01.003. View

19.

Song I, Kim J, Chung S, Lee K . Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals. Eur Neurol. 2009; 62(2):99-104. DOI: 10.1159/000222780. View

20.

Markesbery W, Lovell M . DNA oxidation in Alzheimer's disease. Antioxid Redox Signal. 2006; 8(11-12):2039-45. DOI: 10.1089/ars.2006.8.2039. View